MIBC. Do we need to perform radical cystectomy for patients who are cT0 after NAC?
“Preserving quality of life: avoiding cystectomy after neoadjuvant chemotherapy in muscle invasive bladder cancer”. We aim to address the critical issue of balancing curative intent with preserving patients’ quality of life.
|Organiser||European School of Urology (ESU)|
|Duration||Approx. 60 minutes|
This recorded webinar explores strategies to identify complete responders to neoadjuvant chemotherapy and offers guidance on alternative treatment approaches, sparing many from the challenges of cystectomy. Gain insights, solve dilemmas and enhance patient care by participating in this crucial discussion. Do not miss out on the opportunity to make more informed decision in managing muscle invasive bladder cancer.
- Prof. M. Roupret (FR)
- Dr. A. Van Der Heijden (NL)
- Prof. A. Masson Lecomte (FR)
Made in collaboration with ESOU.
The recording of this webinar is not EU-ACME accredited.
Missed the live session? Earn 1 CME point by completing our online e-course at:
Contact our organiser
European School of Urology (ESU)